Herbalife Analyst Ratings
Herbalife Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/03/2023 | 5.99% | Mizuho | $13 → $17 | Maintains | Neutral |
06/07/2023 | -18.95% | Mizuho | → $13 | Initiates Coverage On | → Neutral |
03/01/2023 | 74.56% | Citigroup | $26 → $28 | Maintains | Buy |
02/03/2023 | -12.72% | B of A Securities | → $14 | Initiates Coverage On | → Underperform |
11/01/2022 | 93.27% | B. Riley Securities | $38 → $31 | Maintains | Buy |
11/01/2022 | 62.09% | Citigroup | $30 → $26 | Maintains | Buy |
10/05/2022 | 87.03% | Citigroup | $36 → $30 | Maintains | Buy |
07/12/2022 | — | Jefferies | Upgrades | Hold → Buy | |
05/17/2022 | — | Argus Research | Downgrades | Buy → Hold | |
05/04/2022 | 155.61% | B. Riley Securities | $50 → $41 | Maintains | Buy |
05/04/2022 | 124.44% | Citigroup | $46 → $36 | Maintains | Buy |
05/04/2022 | 62.09% | Jefferies | $60 → $26 | Downgrades | Buy → Hold |
09/16/2021 | 224.19% | Citigroup | $57 → $52 | Maintains | Buy |
06/29/2021 | 336.41% | B. Riley Securities | → $70 | Initiates Coverage On | → Buy |
05/08/2020 | 249.13% | Citigroup | $49 → $56 | Maintains | Buy |
02/20/2020 | 205.49% | Citigroup | $55 → $49 | Maintains | Buy |
12/04/2019 | 242.89% | Citigroup | → $55 | Assumes | → Buy |
08/02/2019 | 255.36% | Citigroup | $66 → $57 | Maintains | Buy |
10/11/2018 | 305.24% | Jefferies | → $65 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/03/2023 | 5.99% | 瑞穗 | 13 美元 → 17 美元 | 維護 | 中立 |
06/07/2023 | -18.95% | 瑞穗 | → 13 美元 | 啓動覆蓋開啓 | → 中立 |
03/01/2023 | 74.56% | 花旗集團 | 26 美元 → 28 美元 | 維護 | 購買 |
02/03/2023 | -12.72% | B of A 證券 | → 14 美元 | 啓動覆蓋開啓 | → 表現不佳 |
11/01/2022 | 93.27% | B. 萊利證券 | 38 美元 → 31 美元 | 維護 | 購買 |
11/01/2022 | 62.09% | 花旗集團 | 30 美元 → 26 美元 | 維護 | 購買 |
2022年5月10日 | 87.03% | 花旗集團 | 36 美元 → 30 美元 | 維護 | 購買 |
2022 年 12 月 7 日 | — | 傑富瑞 | 升級 | 持有 → 買入 | |
05/17/2022 | — | 阿格斯研究 | 降級 | 買入 → 持有 | |
05/04/2022 | 155.61% | B. 萊利證券 | 50 美元 → 41 美元 | 維護 | 購買 |
05/04/2022 | 124.44% | 花旗集團 | 46 美元 → 36 美元 | 維護 | 購買 |
05/04/2022 | 62.09% | 傑富瑞 | 60 美元 → 26 美元 | 降級 | 買入 → 持有 |
09/16/2021 | 224.19% | 花旗集團 | 57 美元 → 52 美元 | 維護 | 購買 |
06/29/2021 | 336.41% | B. 萊利證券 | → 70 美元 | 啓動覆蓋開啓 | → 購買 |
05/08/2020 | 249.13% | 花旗集團 | 49 美元 → 56 美元 | 維護 | 購買 |
02/20/2020 | 205.49% | 花旗集團 | 55 美元 → 49 美元 | 維護 | 購買 |
2019 年 4 月 12 日 | 242.89% | 花旗集團 | → 55 美元 | 假設 | → 購買 |
2019 年 2 月 8 日 | 255.36% | 花旗集團 | 66 美元 → 57 美元 | 維護 | 購買 |
10/11/2018 | 305.24% | 傑富瑞 | → 65 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Herbalife (HLF)?
康寶萊(HLF)的目標價格是多少?
The latest price target for Herbalife (NYSE: HLF) was reported by Mizuho on August 3, 2023. The analyst firm set a price target for $17.00 expecting HLF to rise to within 12 months (a possible 5.99% upside). 7 analyst firms have reported ratings in the last year.
瑞穗於2023年8月3日公佈了康寶萊(紐約證券交易所代碼:HLF)的最新目標股價。這家分析公司將目標股價定爲17.00美元,預計HLF將在12個月內升至12個月內(可能上漲5.99%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Herbalife (HLF)?
分析師對康寶萊(HLF)的最新評級是多少?
The latest analyst rating for Herbalife (NYSE: HLF) was provided by Mizuho, and Herbalife maintained their neutral rating.
康寶萊(紐約證券交易所代碼:HLF)的最新分析師評級由瑞穗提供,康寶萊維持中性評級。
When is the next analyst rating going to be posted or updated for Herbalife (HLF)?
康寶萊(HLF)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Herbalife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Herbalife was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究(包括瀏覽公開財務報表、與康寶萊的高管和客戶交談以及聽取業績電話會議)後得出股票評級。大多數分析師每三個月進行一次評級,因此每家公司每年應該獲得4個評級。康寶萊的最後一次評級是在2023年8月3日提交的,因此您應該預計下一個評級將在2024年8月3日左右公佈。
Is the Analyst Rating Herbalife (HLF) correct?
分析師對康寶萊 (HLF) 的評級是否正確?
While ratings are subjective and will change, the latest Herbalife (HLF) rating was a maintained with a price target of $13.00 to $17.00. The current price Herbalife (HLF) is trading at is $16.04, which is within the analyst's predicted range.
雖然評級是主觀的,會發生變化,但最新的康寶萊(HLF)評級維持不變,目標股價爲13.00美元至17.00美元。康寶萊(HLF)目前的交易價格爲16.04美元,在分析師的預測區間內。
譯文內容由第三人軟體翻譯。